» Authors » Kyung Hee Jung

Kyung Hee Jung

Explore the profile of Kyung Hee Jung including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 111
Citations 1436
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang H, Kang D, Shin J, Jung J, Ko S, Jung K, et al.
Nat Commun . 2025 Jan; 16(1):353. PMID: 39753537
Conventional chemotherapy- and radiotherapy-induced cancer senescence, which is characterized by poor proliferation, drug resistance, and senescence-associated secretory phenotype, has gained attention as contributing to cancer relapse and the development of...
2.
Nam H, Lee W, Lee Y, Kim J, Jung K, Hong S, et al.
Biomol Ther (Seoul) . 2024 Dec; 33(1):143-154. PMID: 39637922
Pancreatic ductal adenocarcinoma (PDAC) exhibits an altered metabolic profile compared to normal pancreatic tissue. However, studies on actual pancreatic tissues are limited. Untargeted metabolomics analysis was conducted on 54 pairs...
3.
Cho Y, Han B, Ko S, Park M, Lee Y, Kim S, et al.
Int J Mol Med . 2024 Nov; 55(1). PMID: 39540370
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with limited therapeutic options. Cisplatin is a primary chemotherapeutic agent utilized in combination with other drugs or radiotherapy for PDAC treatment. However,...
4.
Han B, Ko S, Park M, Lee Y, Kim S, Lee P, et al.
Int Immunopharmacol . 2024 Sep; 142(Pt B):113207. PMID: 39312860
Surgical resection is the best-known approach for breast cancer treatment. However, post-operative metastases increase the rate of death. The potential effect of anesthetic drugs on long-term tumor growth, risk of...
5.
Jung Y, Lee Y, Dao T, Jung K, Yu J, Oh A, et al.
Clin Mol Hepatol . 2024 Aug; 30(4):895-913. PMID: 39098817
Background/aims: Potassium channel tetramerization domain containing 17 (KCTD17) protein, an adaptor for the cullin3 (Cul3) ubiquitin ligase complex, has been implicated in various human diseases; however, its role in hepatocellular...
6.
Park M, Kim S, Lee P, Lee J, Jung K, Hong S
BMB Rep . 2024 Jul; 57(8):343-351. PMID: 39044455
Angiopoietin-like 4 (ANGPTL4) has been identified as an adipokine involved in several non-metabolic and metabolic diseases, including angiogenesis, glucose homeostasis, and lipid metabolism. To date, the role of ANGPTL4 in...
7.
Lee D, Han B, Jung K, Hong S
Biomol Ther (Seoul) . 2024 Apr; 32(3):281-290. PMID: 38590092
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis owing to its desmoplastic stroma. Therefore, therapeutic strategies targeting this tumor stroma should be developed. In this study, we describe the heterogeneity...
8.
Jung K, Lee S, Kim H, Kim J, Lee Y, Park M, et al.
Exp Mol Med . 2024 Mar; 56(3):721-733. PMID: 38528124
Acetyl-CoA synthetase 2 (ACSS2)-dependent acetate usage has generally been associated with tumorigenesis and increased malignancy in cancers under nutrient-depleted conditions. However, the nutrient usage and metabolic characteristics of the liver...
9.
Jung K, Kim S, Go H, Lee Y, Park M, Ko S, et al.
Biomol Ther (Seoul) . 2023 May; 31(6):599-610. PMID: 37183002
According to recent evidence, ferroptosis is a major cell death mechanism in the pathogenesis of kidney injury and fibrosis. Despite the renoprotective effects of classical ferroptosis inhibitors, therapeutic approaches targeting...
10.
Lee J, Lee P, Yoon Y, Han B, Ko S, Park M, et al.
Biomed Pharmacother . 2023 Apr; 162:114716. PMID: 37086509
Pancreatic ductal adenocarcinoma (PDAC) exhibits a pronounced extracellular matrix (ECM)-rich response, which is produced by an excessive amount of transforming growth factor β (TGF-β), resulting in tumor progression and metastasis....